Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 1;107(4):1008-1010.
doi: 10.3324/haematol.2021.279535.

Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine

Affiliations

Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine

Gaetano Giuffrida et al. Haematologica. .
No abstract available

PubMed Disclaimer

Comment in

References

    1. Miesbach W, Menne J, Bommer M, et al. . Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study. Orphanet J Rare Dis. 2019;14(1):260. - PMC - PubMed
    1. Sukumar S, Lämmle B, Cataland SR. Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management. J Clin Med. 2021;10(3):536. - PMC - PubMed
    1. Yavaşoğlu I. Vaccination and thrombotic thrombocytopenic purpura. Turkish J Hematol. 2020;37(3):218-219. - PMC - PubMed
    1. Yocum A, Simon EL. Thrombotic thrombocytopenic purpura after Ad26.COV2-S vaccination. Am J Emerg Med. 2021:441.e3-441.e4. - PMC - PubMed
    1. Sissa C, Al-Khaffaf A, Frattini F, et al. . Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine. Transfus Apher Sci. 2021:103145. - PMC - PubMed

MeSH terms